- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Company Is Preparing to Enter Its Second High-Growth Market; Outlines Road Map for Growth in New Comprehensive Presentation
Dais Analytic Corporation (PINKSHEETS: DLYT), a developer and manufacturer of nanotechnology materials and products for global markets, has rebranded its innovative desalination process NanoClear™.
The new name emphasizes the superior abilities of Dais's nanotech filtering technology to create clear, clean, potable water from seawater or brackish water while:
-- Reducing or eliminating bacteria, viruses and contaminants,
-- Decreasing fouling and scaling,
-- Preventing brine and waste concentration,
-- Reducing capital costs, and
-- Operating cost-effectively on waste energy or natural energy sources.
NanoClear™ is currently in alpha testing with a Singapore-based engineering and construction firm. Following successful completion of the pilot project, an expanded demonstration and commercialization program for the system will be introduced in select areas of South East Asia and the United States. The technology provides a scalable stand-alone desalination facility that is easier to build and cheaper to operate than current Reverse Osmosis (RO) plants.
Timothy N. Tangredi, CEO, Dais Analytic Corporation, said, "The NanoClear™ pilot unit has demonstrated the strength of the material and the power of the overall process. The material's functionality has been positively reviewed by our Singapore partners. The alpha testing is on-going, and we anticipate completing it on schedule and then moving on to larger, improved pilot projects in the second half of this year.
Mr. Tangredi added, "We are very excited about our timely progress toward entering the desalination market. The American Water Works Association has estimated that $95 billion will be spent on desalination from 2005 to 2015 and approximately $30 billion will be spent on membrane-based systems."
Dais is developing and commercializing innovative products using its nanotechnology materials that address large global markets such as water desalination systems, energy saving devices for use in Heating, Ventilation and Air Conditioning (HVAC) systems, high-performance fabrics, immersion coatings, and ultra-capacitors. The Company currently generates rapidly growing income from its HVAC product ConsERV™. NanoClear™ is Dais's second product being commercialized to address large global markets.
Dais recently produced a comprehensive presentation of its current technologies and a road map for their commercialization over the next 12 to 24 months. Products under development and nearing completion include high-performance fabrics, immersion coatings and an ultra-capacitor cell. This comprehensive overview of the Company's business plans is generating positive responses from investors, especially those interested in high-growth opportunities. For a copy, please email .
About Dais Analytic Corporation
Dais Analytic Corporation (PINKSHEETS: DLYT) is a newly public nanotechnology materials company designing and commercializing new materials and processes that exceed the limits of conventional materials. Dais is one of the few pure plays in the nanotechnology space now earning revenue on its inventions. The Company's materials and products address potential global markets in excess of $3 billion.
Currently, the Company generates revenues from its first commercial product -- ConsERV™ ( http://www.conserv.com ), which is a Heating, Ventilation, and Air Conditioning (HVAC) product saving on average 33% in HVAC capital costs, 30% or more on operational energy costs and 20% peak energy reduction all while improving Indoor Air Quality. For more information about Dais Analytic Corporation, please visit http://www.daisanalytic.com
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made on behalf of the company and its subsidiaries. All such forward-looking statements are, by necessity, only estimates of future results and actual results achieved by the company may differ materially from these statements due to a number of factors. Any forward-looking statements speak only as of the date made. Statements made in this document that are not purely historical are forward-looking statements, including any statements as to beliefs, plans, expectations, or intentions regarding the future. Risk factors that may cause results to differ from projections include, without limitation, loss of suppliers, loss of customers, inadequate capital, competition, loss of key executives, declining prices, and other economic factors. The company assumes no obligations to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. You should independently investigate and fully understand all risks before making investment decisions.
Pursuant to an August 15, 2006 agreement, Consulting For Strategic Growth 1, Ltd. ("CFSG1") provides Dais Analytic Corporation ("the Company") with consulting, business advisory, investor relations, public relations and corporate development services, for which CFSG1 receives a fixed monthly fee for the duration of the agreement. Independent of CFSG1's receipt of cash compensation from the Company, CFSG1 may choose to purchase the Company's common stock and thereafter sell those shares at any time it deems appropriate to do so. For more information please visit http://www.cfsg1.com .
For more information, please click here
Dais Analytic Corporation
11552 Prosperous Drive
Odessa, FL 33556
Tel: (727) 375-8484 x205
Fax: (727) 375-8485
Web sites: http://www.daisanalytic.com
Stanley Wunderlich / Daniel Stepanek
Consulting for Strategic Growth 1
800 Second Avenue
New York, NY 10017
Tel: (800) 625-2236
Fax: (212) 337-8089
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016
Throwing new light on printed organic solar cells December 1st, 2016
'Back to the Future' inspires solar nanotech-powered clothing November 15th, 2016
Stretchy supercapacitors power wearable electronics August 25th, 2016